KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Return on Equity (2016 - 2025)

Amgen (AMGN) has 17 years of Return on Equity data on record, last reported at 0.84% in Q4 2025.

  • For Q4 2025, Return on Equity rose 23.0% year-over-year to 0.84%; the TTM value through Dec 2025 reached 0.84%, up 23.0%, while the annual FY2025 figure was 1.06%, 39.0% up from the prior year.
  • Return on Equity reached 0.84% in Q4 2025 per AMGN's latest filing, up from 0.82% in the prior quarter.
  • Across five years, Return on Equity topped out at 3.94% in Q2 2022 and bottomed at 0.57% in Q2 2024.
  • Average Return on Equity over 5 years is 1.18%, with a median of 0.91% recorded in 2023.
  • Peak YoY movement for Return on Equity: surged 329bps in 2022, then tumbled -263bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 0.79% in 2021, then surged by 127bps to 1.79% in 2022, then plummeted by -46bps to 0.97% in 2023, then plummeted by -37bps to 0.61% in 2024, then soared by 38bps to 0.84% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.84% in Q4 2025, 0.82% in Q3 2025, and 0.97% in Q2 2025.